反応式
Cl.[N:2]12[CH2:9][CH2:8][CH:5]([CH2:6][CH2:7]1)[CH:4]([C:10]([OH:12])=[O:11])[CH2:3]2.C(Cl)CCl.C1C=CC2N(O)N=NC=2C=1.CCN(C(C)C)C(C)C.[F:36][C:37]1[CH:38]=[C:39]([CH:43]([C:45]2[CH:50]=[CH:49][CH:48]=[C:47]([F:51])[CH:46]=2)O)[CH:40]=[CH:41][CH:42]=1>CN(C=O)C.O>[N:2]12[CH2:9][CH2:8][CH:5]([CH2:6][CH2:7]1)[CH:4]([C:10]([O:12][CH:43]([C:39]1[CH:40]=[CH:41][CH:42]=[C:37]([F:36])[CH:38]=1)[C:45]1[CH:50]=[CH:49][CH:48]=[C:47]([F:51])[CH:46]=1)=[O:11])[CH2:3]2参加物
8
反応物 5
生成物 1
試薬・触媒・溶媒 2
実験手順
Quinuclidine-3-carboxylic acid hydrochloride (817 mg, 4.26 mmol), EDC (1.23 g, 6.39 mmol), and HOBT (979 mg, 6.39 mmol) were dissolved in dry DMF (40 ml). DIPEA (2.61 ml, 14.9 mmol) and bis(3-fluorophenyl)methanol (1.03 mg, 4.69 mmol) were added, and the mixture was stirred at room temperature overnight. The mixture was diluted with water and extracted several times with Et2O. The organic phases were collected and washed with brine, dried (Na2SO4), filtered, and evaporated. The residue was purified by flash chromatography (DCM/MeOH=9/1) to obtain bis(3-fluorophenyl)methyl quinuclidine-3-carboxylate (874 mg, racemic mixture).
後処理
- extractionextracted several times with Et2O
- customThe organic phases were collected
- washwashed with brine
- dry with materialdried (Na2SO4)
- filtrationfiltered
- customevaporated
- customThe residue was purified by flash chromatography (DCM/MeOH=9/1)
出典と根拠
- ORDレコード
- ord-e5b17f1598fd4752a8591a206b36f7cb
- 出典データセット
- uspto-grants-2013_12
- 特許番号
- US08604015B2
関連ノート
読み込み中…